Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: This study was designed to investigate the roles of aristolochic acid I (AA-I) and hypokalemia in acute aristolochic acid nephropathy (AAN). Methods: After an adaptation period (1 week), a total of 40 C57BL/6 mice (male, 8 weeks old) were divided into four groups: I (control group), II (low potassium [K] diet), III (normal K diet with administration of AA-I [10 mg/kg weight]), and IV (low K diet with AA-I). After collecting 24 hours of urine at 2 weeks, the mice were sacrificed, and their blood and kidneys were obtained to perform immunochemical staining and/or Western blot analysis. Results: Proteinuria, glycosuria, and increased fractional excretion of sodium and K were prominent in groups III and IV (p < 0.05). Diffuse swelling and poor staining of collecting duct epithelial cells were evident in the medullas of group II. Typical lesions of toxic acute tubular injury were prominent in the cortices of groups III and IV. Α-Smooth muscle actin (α-SMA) was higher in the cortices of the mice in groups III and IV versus group II (p < 0.05), and higher in the medullas of group IV than groups I and III (p < 0.05). E-cadherin was higher in the cortices of groups III and IV compared to group I (p < 0.05). The F4/80 value was higher in the cortices and medullas of groups II, III, and IV compared to group I (p < 0.05), particularly in the case of group II. Conclusions: AA-I can induce acquired Fanconi syndrome in the acute stage of AAN. Macrophages appear to play a key role in the pathogenesis of AAN and hypokalemic nephropathy. It remains uncertain whether hypokalemia plays any role in AAN and hypokalemia.
Abstract
Background/Aims: This study was designed to investigate the roles of aristolochic acid I (AA-I) and hypokalemia in acute aristolochic acid nephropathy (AAN). Methods: After an adaptation period (1 week), a total of 40 C57BL/6 mice (male, 8 weeks old) were divided into four groups: I (control group), II (low potassium [K] diet), III (normal K diet with administration of AA-I [10 mg/kg weight]), and IV (low K diet with AA-I). After collecting 24 hours of urine at 2 weeks, the mice were sacrificed, and their blood and kidneys were obtained to perform immunochemical staining and/or Western blot analysis. Results: Proteinuria, glycosuria, and increased fractional excretion of sodium and K were prominent in groups III and IV (p < 0.05). Diffuse swelling and poor staining of collecting duct epithelial cells were evident in the medullas of group II. Typical lesions of toxic acute tubular injury were prominent in the cortices of groups III and IV. Α-Smooth muscle actin (α-SMA) was higher in the cortices of the mice in groups III and IV versus group II (p < 0.05), and higher in the medullas of group IV than groups I and III (p < 0.05). E-cadherin was higher in the cortices of groups III and IV compared to group I (p < 0.05). The F4/80 value was higher in the cortices and medullas of groups II, III, and IV compared to group I (p < 0.05), particularly in the case of group II. Conclusions: AA-I can induce acquired Fanconi syndrome in the acute stage of AAN. Macrophages appear to play a key role in the pathogenesis of AAN and hypokalemic nephropathy. It remains uncertain whether hypokalemia plays any role in AAN and hypokalemia.
참고문헌 (35)
- Vanherweghem JL, "Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs", Lancet, 341, pp.387~391 (1993)[DOI]
- Depierreux M, "Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs", Am J Kidney Dis, 24, pp.172~180 (1994)[DOI]
- Vanhaelen M, "Identification of aristolochic acid in Chinese herbs", Lancet, 343, pp.174~ (1994)
- Cosyns JP, "Urothelial malignancy in nephropathy due to Chinese herbs", Lancet, 344, pp.188~ (1994)
- Lebeau C, "Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies", Nephrol Dial Transplant, 20, pp.2321~2332 (2005)[DOI]
- Debelle FD, "Aristolochic acid nephropathy: a worldwide problem", Kidney Int, 74, pp.158~169 (2008)[DOI]
- Debelle FD, "Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats", J Am Soc Nephrol, 13, pp.431~436 (2002)
- Sato N, "Acute nephrotoxicity of aristolochic acids in mice", J Pharm Pharmacol, 56, pp.221~229 (2004)[DOI]
- Xue X, "Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury", Nephrol Dial Transplant, 23, pp.3074~3081 (2008)[DOI]
- Cosyns JP, "Aristolochic acid and ‘Chinese herbs nephropathy': a review of the evidence to date", Drug Saf, 26, pp.33~48 (2003)[DOI]
- Reginster F, "Chinese herbs nephropathy presentation, natural history and fate after transplantation", Nephrol Dial Transplant, 12, pp.81~86 (1997)[DOI]
- Izumotani T, "An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs", Nephron, 65, pp.137~140 (1993)[DOI]
- Tsai CS, "An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome", Am J Med Sci, 330, pp.153~155 (2005)[DOI]
- Yang SS, "Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis", Am J Kidney Dis, 39, pp.E14~ (2002)[DOI]
- Izzedine H, "Drug-induced Fanconi's syndrome", Am J Kidney Dis, 41, pp.292~309 (2003)[DOI]
- Linas SL, "Mechanism of the decreased renal blood flow in the potassium-depleted conscious rat", Kidney Int, 21, pp.757~764 (1982)[DOI]
- Whinnery MA, "Effect of potassium deficiency on papillary plasma flow in the rat", Am J Physiol, 237, pp.226~231 (1979)
- Tolins JP, "Hypokalemic nephropathy in the rat: role of ammonia in chronic tubular injury", J Clin Invest, 79, pp.1447~1458 (1987)[DOI]
- Amlal H, "Early polyuria and urinary concentrating defect in potassium deprivation", Am J Physiol Renal Physiol, 279, pp.F655~F663 (2000)[DOI]
- Suga SI, "Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity", Am J Physiol Renal Physiol, 281, pp.F620~F629 (2001)[DOI]
- Pozdzik AA, "Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation", Kidney Int, 73, pp.595~607 (2008)[DOI]
- Reungjui S, "Hypokalemic nephropathy is associated with impaired angiogenesis", J Am Soc Nephrol, 19, pp.125~134 (2008)[DOI]
- Gainza FJ, "Aminoglycoside-associated Fanconi's syndrome: an underrecognized entity", Nephron, 77, pp.205~211 (1997)[DOI]
- Appenroth D, "Efforts to establish an animal model of Fanconi syndrome after ifosfamide administration to rats", J Appl Toxicol, 27, pp.327~336 (2007)[DOI]
- Hsin YH, "Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells", Apoptosis, 11, pp.2167~2177 (2006)[DOI]
- Balachandran P, "Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells", Kidney Int, 67, pp.1797~1805 (2005)[DOI]
- Li Y, "Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro", Arch Toxicol, 80, pp.524~532 (2006)[DOI]
- Liu Y, "Renal fibrosis: new insights into the pathogenesis and therapeutics", Kidney Int, 69, pp.213~217 (2006)[DOI]
- Forino M, "TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture", Int J Exp Pathol, 87, pp.197~208 (2006)[DOI]
- Wilson HM, "Macrophages and the kidney", Curr Opin Nephrol Hypertens, 13, pp.285~290 (2004)[DOI]
- Ghee JY, "The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy", Nephrol Dial Transplant, 23, pp.4061~4069 (2008)[DOI]
- Kang DH, "Role of the microvascular endothelium in progressive renal disease", J Am Soc Nephrol, 13, pp.806~816 (2002)
- Nangaku M, "Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure", J Am Soc Nephrol, 17, pp.17~25 (2006)[DOI]
- Nakagawa T, "Tubulointerstitial disease: role of ischemia and microvascular disease", Curr Opin Nephrol Hypertens, 12, pp.233~241 (2003)[DOI]
- Kang DH, "Impaired angiogenesis in the remnant kidney model. I. Potential role of vascular endothelial growth factor and thrombospondin-1", J Am Soc Nephrol, 12, pp.1434~1447 (2001)